

















Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
Published in Health and Fitness on Tuesday, November 25th 2008 at 9:31 GMT by Market Wire

SAN DIEGO, CA--([ BUSINESS WIRE ])--Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference at The New York Palace in New York City on December 2, 2008, 12:00 p.m. Eastern Time.
A live audio webcast of this presentation will be accessible on the Company's website at [ www.optimerpharma.com ], under the investors section. A replay of this presentation will be available at the same location for thirty days following the meeting.
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. OPT-80 is the only antibiotic therapy currently under Phase 3 worldwide development for Clostridium difficile infection. Prulifloxacin is an antibiotic being developed for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http://[ www.optimerpharma.com ].